LENZ Therapeutics (LENZ) Institutional Ownership → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free LENZ Stock Alerts $15.80 -0.38 (-2.35%) (As of 03:05 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for LENZ Therapeutics (NASDAQ:LENZ)CurrentInstitutional OwnershipPercentage54.32%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$4.93MNumber ofInstitutional Sellers(last 12 months)0 Get LENZ Insider Trade Alerts Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad InvestorPlace1970’s computer coder Issues Shocking AI WarningLouis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP LENZ Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/7/2024 Marquette Asset Management LLC5,865$131K0.0%N/A0.161% 5/2/2024 Jennison Associates LLC134,740$3.01M0.0%N/A3.692% 5/1/2024 BNP Paribas Financial Markets16,221$362K0.0%N/A0.444% 4/25/2024 BML Capital Management LLC63,916$1.43M0.9%N/A1.751% (Data available from 1/1/2016 forward) LENZ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LENZ shares? During the previous two years, the following institutional investors and hedge funds held shares of LENZ Therapeutics shares: Jennison Associates LLC ($3.01M), BML Capital Management LLC ($1.43M), and BNP Paribas Financial Markets ($362K), Marquette Asset Management LLC ($131K).Learn more on LENZ's institutional investors. What percentage of LENZ Therapeutics stock is owned by institutional investors? 54.32% of LENZ Therapeutics stock is owned by institutional investors. Learn more on LENZ's institutional investor holdings. Which institutional investors have been buying LENZ Therapeutics stock? The following institutional investors have purchased LENZ Therapeutics stock in the last 24 months: Jennison Associates LLC ($134.74K), BML Capital Management LLC ($63.92K), BNP Paribas Financial Markets ($16.22K), and Marquette Asset Management LLC ($5.87K). How much institutional buying is happening at LENZ Therapeutics? Institutional investors have bought a total of 220,742 shares in the last 24 months. This purchase volume represents approximately $4.93M in transactions. Related Companies: CDTX Institutional Ownership ALGS Institutional Ownership AVRO Institutional Ownership IKNA Institutional Ownership TSBX Institutional Ownership DTIL Institutional Ownership ELUT Institutional Ownership GNTA Institutional Ownership TIL Institutional Ownership QNCX Institutional Ownership This page (NASDAQ:LENZ) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 Media348 million Americans lives to END as we know it?The Oxford ClubUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.